Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 168.27
-5.07 (-2.92%)
At close: Mar 9, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 11.26 billion as of March 9, 2026. Its market cap has decreased by -25.78% in one year.
Market Cap
11.26B
Enterprise Value
9.75B
Revenue
2.82B
Ranking
n/a
PE Ratio
27.74
Stock Price
168.27
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 11.26B, a decrease of -36.16%. That is a compound annual growth rate of -1.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 11.75B |
| Ind-Swift Laboratories | 11.87B |
| Beta Drugs | 11.08B |
| Windlas Biotech | 15.58B |
| Indoco Remedies | 18.31B |
| Sigachi Industries | 7.31B |
| Solara Active Pharma Sciences | 22.11B |
| Orchid Pharma | 25.79B |